Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091667 Clear, colorless solution; mixture of surfactant and microbiocide
05/15/2003US20030091660 Product
05/15/2003US20030091658 Herbal pharmaceutical composition for treatment of HIV/AIDS patients
05/15/2003US20030091654 Dietetics, antidiabetic agents; using chromium complex
05/15/2003US20030091651 Oil homogenized with sterols; protective coating for stomach
05/15/2003US20030091650 Ratite oil as a topical adjuvant and transdermal carrier
05/15/2003US20030091649 ICAM-1 formulation having controlled-size microparticles
05/15/2003US20030091648 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins
05/15/2003US20030091647 Variation in zeta potential between microstructure and nanostructure; solidification, crystallization sedimentation
05/15/2003US20030091645 Organic compounds
05/15/2003US20030091644 Low concentration of peroxide for treating or preventing vaginal infections
05/15/2003US20030091643 Amorphous mixture of acid sensitive drug and addition polymer; chemical resistance, stability
05/15/2003US20030091642 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
05/15/2003US20030091639 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/15/2003US20030091638 Overcoating with polymer; sustained release
05/15/2003US20030091637 Drug core with polymeric overcoating
05/15/2003US20030091636 Antiinflammatory agents; uniform dissolving; oral bioavailability
05/15/2003US20030091635 Sustained release; reduced tendency to drug abruse
05/15/2003US20030091634 Delayed release tablet of venlafaxin
05/15/2003US20030091633 Pure form; cardiovascular disorders; side effect reduction
05/15/2003US20030091632 Controlled-release sedative-hypnotic compositions and methods related thereto
05/15/2003US20030091631 Method of providing sustained analgesia with buprenorphine
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091629 Absorption; pH adjustment; bioavailability
05/15/2003US20030091628 Anhydrous; granulation, compression; dryness; antidepressants
05/15/2003US20030091627 Rate-controlled delivery of macrolides
05/15/2003US20030091626 Dispersion, ejection melt containing sugar; controlling temperature; solvent-free; freeze drying
05/15/2003US20030091625 Method and device for producing compression coated tablets
05/15/2003US20030091624 Simethicone solid oral dosage form
05/15/2003US20030091623 Solid oral dosage form containing an enhancer
05/15/2003US20030091622 Process for producing composite preparation containing nucleic acid
05/15/2003US20030091621 Encapsulated drugs
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091619 Temporomandibular joint patch
05/15/2003US20030091616 Method for making infection-resistant fabricated textile articles for biomedical applications
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091610 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
05/15/2003US20030091603 Polyoxyethylene dicarboxylic acid
05/15/2003US20030091600 Hydrophilic colloid as thickener; opacity
05/15/2003US20030091595 West nile vaccine
05/15/2003US20030091583 Use of mia in immunotheraphy
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091559 Biocompatibility; liquid phase
05/15/2003US20030091558 Storage-stable fibrinogen solutions
05/15/2003US20030091552 Nutraceutical composition
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091545 Insoluble collagen matrix containing cells, microspheresc and promoters
05/15/2003US20030091540 Uniform spreading into body cavities
05/15/2003US20030091528 Mixing an opaque mixture under pressure
05/15/2003US20030091519 Synergistic mixture of organosulfur compound and urea; intensify penetration
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003US20030091517 Andrographis paniculata gel as an adjunct in the treatment of periodontitis
05/15/2003US20030091513 For drugs, pigments
05/15/2003US20030091512 Water stabilized medicinal aerosol formulation
05/15/2003US20030091511 Vaporization, cooling; forming aerosols; anxiolytic agents
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030091509 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
05/15/2003US20030090039 Continuous production of pharmaceutical granulation
05/15/2003US20030090015 Method for manufacturing seamless capsule
05/15/2003US20030089369 Pressurised metered dose inhalers (MDI)
05/15/2003CA2474196A1 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003CA2472055A1 Improved mucosal vaccines and methods for using the same
05/15/2003CA2466425A1 Photodynamic therapy for the treatment of hair loss
05/15/2003CA2466336A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003CA2466335A1 Surface coated capsules
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466083A1 Compositions for the treatment of infectious diseases
05/15/2003CA2466061A1 Oral adhering and dissolving disc made by deposition with licorice extract
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465920A1 Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
05/15/2003CA2465897A1 Porous polymeric prostheses and methods for making same
05/15/2003CA2465756A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003CA2465753A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003CA2465496A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003CA2465159A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003CA2465110A1 Tamsulosin tablets
05/15/2003CA2464756A1 Method for the formation of ibuprofen crystals
05/15/2003CA2464528A1 Pharmaceutical composition
05/15/2003CA2464217A1 Antimuscarinic aerosol
05/15/2003CA2463942A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
05/14/2003EP1310517A1 Lactic acid polymer and process for producing the same
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310268A2 Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
05/14/2003EP1310254A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
05/14/2003EP1310253A1 Niacin-containing sustained-release tablets and kits
05/14/2003EP1310252A1 Injections
05/14/2003EP1310249A1 Use of polyunsatured fatty acids for the primary prevention of major cardiovascular events
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1310245A1 Clopidogrel bisulfate tablet formulation
05/14/2003EP1310244A2 Compositions comprising an anticancer agent and a polyether block copolymer
05/14/2003EP1310243A1 Novel formulation
05/14/2003EP1310242A1 Carrier and kit for endoluminal delivery of active principles
05/14/2003EP1310233A2 Process for making compositions comprising titanium dioxide
05/14/2003EP1310229A1 Method of manufacturing seamless capsule
05/14/2003EP1309640A1 Polyurethane film-forming dispersions in alcohol-water system
1 ... 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 ... 2991